UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000051907
Receipt number R000059142
Scientific Title Visual function of eyes implanted with non-diffractive extended depth of focus intraocular lens
Date of disclosure of the study information 2023/08/14
Last modified on 2023/08/14 22:00:18

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Visual function of eyes implanted with non-diffractive extended depth of focus intraocular lens

Acronym

Visual function of non-diffractive EDOF IOL

Scientific Title

Visual function of eyes implanted with non-diffractive extended depth of focus intraocular lens

Scientific Title:Acronym

Visual function of non-diffractive EDOF IOL

Region

Japan


Condition

Condition

cataract

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the visual function of Japanese eyes implamted with non-diffractive extended depth of focus intraocular lens 3 years postoperatively

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Binocular best corrected visual acuity (5m) at 3 months postoperatively

Key secondary outcomes

Visual acuity at 3 months postoperatively
1) Monocular uncorrected visual acuity (5m, 66cm, 40cm)
2) Monocular distance corrected visual acuity (5m, 66cm, 40cm)
3) Binocular uncorrected visual acuity (5m, 66cm, 40cm)
4) Binocular distance corrected visual acuity (66cm, 40cm)


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Patients with bilateral age-related cataracts who are scheduled to have Clareon Vivity inserted in both eyes
(2) Patients with preoperative corneal astigmatism of 0.75 D or less in both eyes
(3) Patients who can expect a post-operative distance-corrected decimal visual acuity of 0.7 or better in one eye.

Key exclusion criteria

(1) Patients with conditions other than cataract that may affect the endpoints
(2) Patients with corneal irregular astigmatism
(3) Patients with a history of corneal refractive surgery, intraocular surgery and corneal surgery
(4) Patients who are judged to be inappropriate by the principal investigator or a sub-investigator because of other systemic or ophthalmological diseases.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Hiroko
Middle name
Last name Bissen

Organization

Tokyo Dental College Suidobashi Hospital

Division name

Department of Ophthalmology

Zip code

101-0061

Address

2-9-18, Kandamisaki-cho, Chiyoda-ku

TEL

03-5275-1856

Email

bissen@tdc.ac.jp


Public contact

Name of contact person

1st name Yuka
Middle name
Last name Ota

Organization

Tokyo Dental College Suidobashi Hospital

Division name

Department of Ophthalmology

Zip code

101-0061

Address

2-9-18, Kandamisaki-cho, Chiyoda-ku

TEL

03-5275-1856

Homepage URL


Email

yota@tdc.ac.jp


Sponsor or person

Institute

Tokyo Dental College

Institute

Department

Personal name



Funding Source

Organization

Alcon Japan

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

NPO MINS

Address

#2, 1-15-14, Dogenzaka, Shibuya-ku

Tel

03-6416-1868

Email

npo-mins@j-irb.com


Secondary IDs

Secondary IDs

YES

Study ID_1

JCS#86884787

Org. issuing International ID_1

NPO MINS

Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京歯科大学水道橋病院(東京都)、医療法人メビア 戸塚駅前鈴木眼科(神奈川県)、善行すずき眼科(神奈川県)、スカイビル眼科医院(神奈川県)


Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 04 Month 22 Day

Date of IRB

2023 Year 05 Month 18 Day

Anticipated trial start date

2023 Year 07 Month 25 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

No concomitant prohibited therapies are set.


Management information

Registered date

2023 Year 08 Month 14 Day

Last modified on

2023 Year 08 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000059142


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name